EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pulsed field ablation in patients with cardiac implantable electronic devices: an ex vivo assessment of safety

Carsten Lennerz, Matthew O'Connor, Claudia Schaarschmidt, Tilko Reents, Felix Bourier, Marta Telishevska, Sarah Lengauer, Miruna Popa, Katharina Wimbauer, Ellen Holmgren, Mara Thoma, Lovis Spitzauer und 10 weitere

Journal of Interventional Cardiac Electrophysiology · 2024

DOI: 10.1007/s10840-024-01758-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Interventional Cardiac Electrophysiology, 2024. Verfasst von Carsten Lennerz und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrophysiology, German Heart Centre Munich, Technical University of Munich, Lazarettstr. 36, 80636, Munich, Germany. lennerz@dhm.mhn…. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Pacemaker, Artificial, Catheter Ablation. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulse field ablation (PFA) is a novel catheter ablation technology with potential safety benefits due to its tissue selectivity. It has the potential to directly damage or interact with the functionality of cardiac implantable electronic devices (CIEDs) in the form of electromagnetic interference (EMI). The aim of our study was to assess the impact of PFA on CIEDs.

Methods

PFA lesions (45 per CIED) were applied from the Farapulse system to CIEDs (< 5 cm from the lead tip and < 15 cm from the generator). All devices were checked before and after PFA application for proper sensing and pacing functionality as well as for integrity of shock circuits in ICDs using a heart simulator. Moreover, devices were then interrogated for any spontaneous reprogramming, mode switching or other EMI effects.

Results

In total, 44 CIEDs were tested (16 pacemaker, 21 ICDs, 7 CRT-P/D) with 1980 PFA applications. There was no change in device settings, functionality and electrical parameters, and there was no macroscopic damage to the devices. The risk of damage to the electric components or leads on a patient-based analysis is 0/44 (95% CI 0–8%) and on a PFA pulse-based analysis is 0/1980 (95% CI 0–0.2%). Clinically relevant EMI appeared with oversensing and pacing inhibition but not tachycardia detection.

Conclusions

Bipolar PFA appears safe and does not result in damage to CIEDs or leads. Clinically relevant EMI does occur, but appropriate peri-procedural programming may mitigate this. In vivo studies are needed to confirm our findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantablePacemaker, ArtificialCatheter AblationHumansEquipment SafetyIrreversible Electroporation TherapyEquipment Failure AnalysisTreatment OutcomeFemalePatient Safety

Stichwörter der Autor:innen

Atrial fibrillation ablationElectromagnetic interferenceImplantable cardioverter-defibrillatorPacemakerPulsed field ablation

Autor:innen und Institutionen

  • Department of Electrophysiology, German Heart Centre Munich, Technical University of Munich, Lazarettstr. 36, 80636, Munich, Germany. lennerz@dhm.mhn.de.
  • DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany. lennerz@dhm.mhn.de.
  • Cardiology Department, Auckland City Hospital, Auckland, New Zealand.
  • Department of Electrophysiology, German Heart Centre Munich, Technical University of Munich, Lazarettstr. 36, 80636, Munich, Germany.
  • DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.

Zitieren

APA

Lennerz, C., O'Connor, M., Schaarschmidt, C., Reents, T., Bourier, F., Telishevska, M., Lengauer, S., Popa, M., Wimbauer, K., Holmgren, E., Thoma, M., Spitzauer, L., Bahlke, F., Krafft, H., Englert, F., Knoll, K., Friedrich, L., Blazek, P., Hessling, G., …, & Kottmaier, M. (2024). Pulsed field ablation in patients with cardiac implantable electronic devices: an ex vivo assessment of safety. Journal of Interventional Cardiac Electrophysiology. https://doi.org/10.1007/s10840-024-01758-2

Vancouver

Lennerz C, O'Connor M, Schaarschmidt C, Reents T, Bourier F, Telishevska M, et al. Pulsed field ablation in patients with cardiac implantable electronic devices: an ex vivo assessment of safety. Journal of Interventional Cardiac Electrophysiology. 2024. doi:10.1007/s10840-024-01758-2

BibTeX
@article{Lennerz2024,
  author = {Lennerz, Carsten and O'Connor, Matthew and Schaarschmidt, Claudia and Reents, Tilko and Bourier, Felix and Telishevska, Marta and Lengauer, Sarah and Popa, Miruna and Wimbauer, Katharina and Holmgren, Ellen and Thoma, Mara and Spitzauer, Lovis and Bahlke, Fabian and Krafft, Hannah and Englert, Florian and Knoll, Katharina and Friedrich, Lena and Blazek, Patrick and Hessling, Gabriele and Kolb, Christof and Deisenhofer, Isabel and Kottmaier, Marc},
  title = {Pulsed field ablation in patients with cardiac implantable electronic devices: an ex vivo assessment of safety},
  journal = {Journal of Interventional Cardiac Electrophysiology},
  year = {2024},
  doi = {10.1007/s10840-024-01758-2}
}
Kostenlos starten →